Rep. Lisa Mazur’s HB 701 will legally address consent and civil liability to allow dying patients in NH to access new forms of potentially life-saving treatment if passed. This right-to-try law makes it possible for terminally ill patients to try new paths of healing without worrying doctors and lawyers about liability. In addition to the amended version of the bill, below are some resources explaining the details and significance of this law.
- HB 701 as amended by the House
- An op-ed by Cornerstone’s Ian Huyett explaining the significance of this bill in making NH a leading biotech destination in the country
- An op-ed by Michael Yakubovich from a terminally diagnosed patient’s perspective on why NH must choose hope
- A personal testimony from Dr. Bess Stillman whose husband died unable to try experimental treatment
- A personal testimony from the Corman family and signed letter by multiple concerned parents of children with rare, terminal genetic illnesses
- An executive summary on HB 701 that gives a succinct, detailed overview of what the bill does and how it works
- The story of KJ Muldoon – A miracle of the world’s first personalized gene-editing treatment
- A commentary by Jared Rhoads at the Center for Modern Health
- A recorded X space featuring the sponsor Lisa Mazur, testimonies from Michael Yakubovich and Dr. Stillman, and legal aspects by Ian Huyett as well as dialog with listeners.
- X Space Part 2 with representatives, Ian Huyett, and constituent testimonies
- X Space Part 3 featuring the sponsor, Lisa Mazur, and testimonies from other representatives, constituents, and concerned patients
- A commentary on children with rare diseases who would come to NH for treatment if HB 701 passes as recommended by Senate HHS
Contact us for questions.
